info iconCurrently, the share price for Jenburkt Pharmaceuticals Ltd. is delayed.

close icon
Jenburkt Pharmaceuticals Ltd. Logo

Jenburkt Pharmaceuticals Ltd.

₹885.55
BSE
--   ( -- %) 1D



  • Prev. Close
    885.55
  • Upper Circuit
    1,062.65
  • Lower Circuit
    708.45

Analyst Sentiment For Jenburkt Pharmaceuticals Ltd.

Info icon
There seem to be no recommendations on this stock from the analyst universe covered

Returns

Jenburkt Pharmaceuticals Ltd.'s Info & Management

Jenburkt Pharmaceuticals is in the business of manufacturing, producing, developing and marketing a wide range of branded Pharmaceuticals and health care products.
  • Senior Vice President
    Mahender Paul Singh
  • Head(International Business)
    Vinay L. Bhatt
  • Vice President
    Uday Kalele
  • Chief Financial Officer
    Dilip H Bhuta
  • General Manager
    Jayesh D. Tanna
  • Company Secretary,Compliance Officer
    Ashish R Shah

FAQs on Jenburkt Pharmaceuticals Ltd.

What is the share price of Jenburkt Pharmaceuticals Ltd.?

Jenburkt Pharmaceuticals Ltd. share price is ₹845.15 as of May 30, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Jenburkt Pharmaceuticals Ltd.?

The 52-week high and low of Jenburkt Pharmaceuticals Ltd. is ₹925.00 and ₹586.90 respectively as of May 30, 2024, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of Jenburkt Pharmaceuticals Ltd.?

The trailing twelve month (TTM) PB ratio of Jenburkt Pharmaceuticals Ltd. is 2.70 as of May 30, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of Jenburkt Pharmaceuticals Ltd.?

The Upper Circuit of Jenburkt Pharmaceuticals Ltd. is ₹1,063. The Lower Circuit of Jenburkt Pharmaceuticals Ltd. is ₹708.

What is the ROE of Jenburkt Pharmaceuticals Ltd.?

Jenburkt Pharmaceuticals Ltd. reported an ROE of 19.43% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Jenburkt Pharmaceuticals Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Jenburkt Pharmaceuticals Ltd., Promoter held 47.2%, and the public held 52.8% of the total shares.

How to buy Jenburkt Pharmaceuticals Ltd. Share?

You can easily buy shares of Jenburkt Pharmaceuticals Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Jenburkt Pharmaceuticals Ltd.?

The fair value of Jenburkt Pharmaceuticals Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer